Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery

British Journal of Ophthalmology

Volumn 98, Issue 10, 2014, Pages 1320-1324

  Kiire, Christine A ^a   Mukherjee, Rajarshi ^a   Ruparelia, Neil ^b   Keeling, David ^b   Prendergast, Bernard ^b   Norris, Jonathan H ^a  

^a OXFORD EYE HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; APIXABAN; CANGRELOR; CLOPIDOGREL; DABIGATRAN; ELINOGREL; HEPARIN; PRASUGREL; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; CATARACT EXTRACTION; CORNEA SURGERY; DRUG USE; ELECTIVE SURGERY; EYE SURGERY; GLAUCOMA SURGERY; HUMAN; LOCAL ANESTHESIA; OCULOPLASTIC SURGERY; PATIENT CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREOPERATIVE CARE; REVIEW; RISK ASSESSMENT; STRABISMUS SURGERY; SURGICAL RISK; SURGICAL TECHNIQUE; UNITED KINGDOM; VITREORETINAL SURGERY; BIOCHEMISTRY; DIAGNOSTIC TESTS/INVESTIGATION; PEROPERATIVE COMPLICATION; TREATMENT SURGERY;

BIOCHEMISTRY; DIAGNOSTIC TESTS/INVESTIGATION; TREATMENT SURGERY;

ANTICOAGULANTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PLATELET AGGREGATION INHIBITORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 84905091387     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-304902     Document Type: Review

References (46)

1. Pudusseri A, Shameem R, Spyropoulos AC. A new paradigm shift in antithrombotic therapy. Front Pharmacol 2013;4:133.
2. Tanguay JF, Bell AD, Ackman ML, et al. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. Can J Cardiol 2013;29:1334-45.
3. NICE. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. London: National Institute for Health and Care Excellence, 2002.
4. NICE. Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults. London: National Institute for Health and Care Excellence, 2012.
5. NICE. Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults. London: National Institute for Health and Care Excellence, 2008.
6. NICE. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. London: National Institute for Health and Care Excellence, 2012.
7. NICE. Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. London: National Institute for Health and Care Excellence, 2009.
8. NICE. Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. London: National Institute for Health and Care Excellence, 2012.
9. NICE. Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism. London: National Institute for Health and Care Excellence, 2012.
10. NICE. Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism. London: National Institute for Health and Care Excellence, 2013.
11. NICE. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention. London: National Institute for Health and Care Excellence, 2009.
12. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2:349-60.
13. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.
14. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
15. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107: 1692-711.
16. Hirsh J, Anand SS, Halperin JL, et al. Guide to anticoagulant therapy: Heparin: a statement for healthcare professionals from the American Heart Association. Circulation 2001;103:2994-3018.
17. Ansell J, Bergqvist D. Current options in the prevention of thromboembolic disease. Drugs 2004;64(Suppl 1):1-5.
18. Jaichandran V. Ophthalmic regional anaesthesia: a review and update. Indian J Anaesth 2013;57:7-13.
19. Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth 2000;85:708-11.
20. Kumar N, Jivan S, Thomas P, et al. Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006;32:1022-5.
21. Campbell RJ, Bell CM, Paterson JM, et al. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis. Ophthalmology 2012;119:1604-8.
22. Charles S, Rosenfeld PJ, Gayer S. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 2007;27: 813-15.
23. Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003;110:1784-8.
24. Obuchowska I, Mariak Z. Risk factors of massive suprachoroidal hemorrhage during extracapsular cataract extraction surgery. Eur J Ophthalmol 2005;15:712-17.
25. Morgan WH, Yu DY. Surgical management of glaucoma: a review. Clin Experiment Ophthalmol 2012;40:388-99.
26. Law SK, Song BJ, Yu F, et al. Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol 2008;145:736-46.
27. Cobb CJ, Chakrabarti S, Chadha V, et al. The effect of aspirin and warfarin therapy in trabeculectomy. Eye 2007;21:598-603.
28. Nguyen QH, Budenz DL, Parrish RK II. Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol 1998;116:571-5.
29. Fabinyi DC, O'Neill EC, Connell PP, et al. Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Experiment Ophthalmol 2011;39:878-84.
30. Brown JS, Mahmoud TH. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 2011;31:1983-7.
31. Khuthaila MK, Hsu J, Chiang A, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol 2013;155:757-63, 63 e1-2.
32. Karim R, Ghabrial R, Lynch T, et al. A comparison of external and endoscopic endonasal dacryocystorhinostomy for acquired nasolacrimal duct obstruction. Clin Ophthalmol 2011;5:979-89.
33. Terella AM, Wang TD, Kim MM. Complications in periorbital surgery. Facial Plast Surg 2013;29:64-70.
34. Kent TL, Custer PL. Bleeding complications in both anticoagulated and nonanticoagulated surgical patients. Ophthal Plast Reconstr Surg 2013;29:113-17.
35. Custer PL, Trinkaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg 2002;18:409-15.
36. Lewis KG, Dufresne RG Jr. A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg 2008;34:160-4; discussion 64-5.
37. Ares C, Superstein R. Retrobulbar hemorrhage following strabismus surgery. J Aapos 2006;10:594-5.
38. Price FW Jr., Whitson WE, Ahad KA, et al. Suprachoroidal hemorrhage in penetrating keratoplasty. Ophthalmic Surg 1994;25:521-5.
39. Koenig SB. Delayed massive suprachoroidal hemorrhage after descemet stripping automated endothelial keratoplasty. Cornea 2011;30:818-19.
40. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270-382.
41. Acedillo RR, Shah M, Devereaux PJ, et al. The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis. Ann Surg 2013;258:901-13.
42. Wong WW, Gabriel A, Maxwell GP, et al. Bleeding risks of herbal, homeopathic, and dietary supplements: a hidden nightmare for plastic surgeons?. Aesthet Surg J 2012;32:332-46.
43. Pribitkin ED, Boger G. Herbal therapy: what every facial plastic surgeon must know. Arch Facial Plast Surg 2001;3:127-32.
44. Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin -fourth edition. Br J Haematol 2011;154:311-24.
45. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003;163:901-8.
46. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e326S-50S.